Please login to the form below

Not currently logged in
Email:
Password:

oncology

This page shows the latest oncology news and features for those working in and with pharma, biotech and healthcare.

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

The combination of Opdivo and Yervoy lies at the heart of much of Bristol-Myers Squibb’s ambition in immuno-oncology, and an FDA approval for the pairing in kidney cancer

Latest news

More from news
Approximately 376 fully matching, plus 1,018 partially matching documents found.

Latest Intelligence

  • Beyond caring: learning from the unsung advocates in cancer care

    In an effort to better understand the role of cancer carers in the UK and what can be done to offer them greater support, Havas Lynx’s Switched Oncology initiative invited ... Steffi Evans is a medical writer and executive faculty member of Switched

  • The rise of real-world evidence The rise of real-world evidence

    The evidence has applications in multiple therapeutic areas. Roche showed the value it places on real-world cancer evidence when it struck a $1.9bn (£1.3bn) deal to acquire oncology

  • Let’s change the conversation about cancer Let’s change the conversation about cancer

    This changing conversation was explored at a recent focus group organised by Havas Lynx as part of their Switched Oncology initiative. ... The group discussed the impact of recent developments in cancer therapies, such as immuno-oncology (IO).

  • Deal Watch January 2018

    Licence. 339. TeneoBio/TESARO. Multi-specific antibodies for up to six undisclosed oncology targets using UniRat® platform and discovery engine TeneoSeek. ... used to progress the clinical development of the company's immuno-oncology antibody

  • A marathon and a sprint A marathon and a sprint

    At Lucid, we did it with oncology KOLs at a European congress. ... A good example of this was a research trip to sub-Saharan Africa for the development of an access-to-medicines platform for oncology.

More from intelligence
Approximately 14 fully matching, plus 161 partially matching documents found.

Latest appointments

  • Targovax strengthens board of directors Targovax strengthens board of directors

    Patrick Vink, chairman of the board at Targovax, said: “We are delighted to welcome Catherine, she brings extensive international oncology expertise and insights that will further strengthen the board. ... She has had a long and distinguished career

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    We believe this therapy has the potential to significantly impact the treatment approach and outcomes for patients with multiple myeloma, ”said Nadim Ahmed, head of Celgene’s haematology and oncology division.

  • Cognite strengthens team with two new additions Cognite strengthens team with two new additions

    She has demonstrated real drive and talent across a wide range of disease areas including oncology, MS, diabetes and Alzheimer’s, making her ideally suited to help build successful breakthrough science

  • Lilly appoints Maura Dickler as VP of late phase oncology development Lilly appoints Maura Dickler as VP of late phase oncology development

    Maura Dickler is set to join Lilly Oncology as VP of late phase development on May 7. ... In her new role at Lilly Oncology she will report to senior vice president, global development and medical affairs Levi Garraway.

  • EUSA Pharma appoints Rolf Hoffmann to its board EUSA Pharma appoints Rolf Hoffmann to its board

    Oncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman. ... Bryan Morton, executive chairman at EUSA Pharma, said: “Rolf’s strategic insight and guidance, based on significant commercial

More from appointments
Approximately 12 fully matching, plus 250 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 36 fully matching, plus 75 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics